China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
21.93
-0.39 (-1.75%)
At close: Feb 13, 2026

SHE:300294 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
11,05815,26916,98318,43519,33814,286
Market Cap Growth
-24.38%-10.10%-7.88%-4.67%35.36%7.40%
Enterprise Value
7,95210,03511,91913,97817,73114,221
Last Close Price
21.9329.9132.8035.4136.9632.27
PE Ratio
33.7338.4671.5242.6656.1354.93
Forward PE
19.3426.0029.0030.9532.4032.75
PS Ratio
5.638.806.406.687.305.69
PB Ratio
1.442.042.322.532.793.41
P/TBV Ratio
1.762.552.432.973.234.40
P/FCF Ratio
-149.7130.6440.2515.1424.80
P/OCF Ratio
174.1950.9326.4730.9114.3719.88
EV/Sales Ratio
4.055.784.495.076.695.66
EV/EBITDA Ratio
22.0919.3019.0923.2834.7234.56
EV/EBIT Ratio
30.9423.7722.5227.5642.7843.07
EV/FCF Ratio
-18.5898.4021.5130.5213.8824.69
Debt / Equity Ratio
0.000.000.000.010.010.08
Debt / EBITDA Ratio
0.020.020.040.060.070.80
Debt / FCF Ratio
-0.120.040.080.030.57
Net Debt / Equity Ratio
-0.40-0.47-0.72-0.64-0.61-0.10
Net Debt / EBITDA Ratio
-8.71-6.71-8.49-7.81-8.32-1.03
Net Debt / FCF Ratio
7.26-34.18-9.56-10.24-3.33-0.73
Asset Turnover
0.230.210.330.350.420.48
Inventory Turnover
1.000.792.061.871.741.61
Quick Ratio
4.295.4012.857.657.831.71
Current Ratio
5.576.7414.088.618.953.36
Return on Equity (ROE)
4.29%5.36%3.40%6.27%6.45%6.73%
Return on Assets (ROA)
1.90%3.25%4.17%4.05%4.05%3.96%
Return on Invested Capital (ROIC)
5.50%11.64%16.09%16.13%10.41%7.09%
Return on Capital Employed (ROCE)
3.30%5.50%7.20%6.90%5.90%7.70%
Earnings Yield
2.96%2.60%1.40%2.34%1.78%1.82%
FCF Yield
-3.87%0.67%3.26%2.48%6.60%4.03%
Dividend Yield
1.37%1.07%0.92%0.56%0.41%0.20%
Payout Ratio
72.56%58.54%42.47%19.25%13.36%34.15%
Buyback Yield / Dilution
0.22%0.54%-0.53%-15.24%-2.30%-0.04%
Total Shareholder Return
1.56%1.61%0.38%-14.67%-1.89%0.16%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.